NAT10 and cancer: Through high-throughput sequencing analysis of NAT10-depleted cancer cells, fatty acid metabolism emerged as the top enriched pathway among differential downregulation genes [93], suggesting NAT10 plays a positive regulatory role in fatty acid metabolism.